-
Australia’s CSIRO starts first stage of coronavirus vaccine testing
pharmaceutical-technology
April 03, 2020
The Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Australia has begun the first stage of testing of two potential Covid-19 vaccines.
-
Aptorum to investigate use of repurposed drug candidates for coronavirus
pharmaceutical-business-review
April 02, 2020
Aptorum Group has joined forces with Covar Pharmaceuticals for studying the use of three repurposed drug candidates for the treatment of novel coronavirus (COVID-19).
-
Beckman Coulter Announces Test Development for Coronavirus Antibodies
americanpharmaceuticalreview
April 02, 2020
In response to the global COVID-19 pandemic, Beckman Coulter is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2.
-
VBI Vaccines to develop pan-coronavirus vaccine
pharmaceutical-technology
April 02, 2020
VBI Vaccines has partnered with the National Research Council of Canada (NRC) to create a pan-coronavirus vaccine candidate.
-
Aptorum and Covar explore repurposed drugs for coronavirus
pharmaceutical-technology
April 01, 2020
Aptorum Group is set to choose at least three repurposed drug candidates for Covid-19 treatment, out of nearly 2,600 approved small drug molecules screened using its Smart-ACT drug discovery platform.
-
A wake-up call for One Health
expresspharma
April 01, 2020
As an important stakeholder of global health security, it is time for the pharma sector to embrace newer approaches and strategies which are in line with One Health principles to be a worthy warrior in the war against zoonoses.
-
Advarra Offers Complimentary Transfer of IRB Oversight
contractpharma
March 31, 2020
Provides access to eRegulatory management software and a dedicated resource for guidance on emerging issues impacted by COVID-19.
-
Eurofins Launches Coronavirus Testing Solutions
contractpharma
March 31, 2020
Eurofins Technologies has launched GeneScan VIRSeek SARS-CoV-2 RT-PCR, an integrated solution including RNA extraction and test kits based on real-time RT-PCR (Reverse transcription polymerase chain reaction) for the detection of SARS-CoV-2 in swabs of en
-
Novartis CEO says Malaria drug is biggest hope against coronavirus – SonntagsZeitung
expresspharma
March 31, 2020
Other companies including Bayer and Teva have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing its experimental drug remdesivir against coronavirus.
-
95 percent of pharma industry concerned about COVID-19 impact, finds survey
europeanpharmaceuticalreview
March 30, 2020
The survey indicates that almost all respondents were concerned about the COVID-19 pandemic’s effects on company performance, including supply and demand failures.